WASHINGTON, January 5. / TASS /. The Food and Drug Administration under the US Department of Health and Human Services (FDA) believes it is premature to reduce the dosage for coronavirus vaccinations. This is stated in a statement released on Monday by the regulator.
“We are monitoring discussions and reports about reducing the number of doses, the interval between uses, changing the dose (half the dose) or mixing drugs to vaccinate more people. These reasonable questions need to be considered and evaluated in clinical trials,” the text says. it is premature to change the approved administration dosage and schedule of vaccines at this time, it is not justified by the available information."
According to representatives of the department, without the availability of relevant information, the introduction of changes poses a risk to public health.
American immunologist Moncef Slowey, who leads a team of scientists involved in the government's vaccine development and distribution program, told CBS on January 3 that the authorities are discussing the possibility of using only half the dose of Modern's drug in vaccination to speed up the process and increase population coverage.
On December 11, FD approved a vaccine developed by Pfizer and BioNTech. On December 18, the Moderna vaccine received a similar approval from the regulator. US President Donald Trump said on January 1 that a number of US states are very slow to vaccinate against coronavirus infection.